Valuation dashboard for Senseonics Holdings, Inc. (SENS) with P/E N/A, P/B 5.75, EV/EBITDA -3.69 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
Senseonics Holdings, Inc. operates as a medical technology enterprise, specializing in the development and commercialization of continuous glucose monitoring (CGM) systems. These innovative solutions cater to individuals with diabetes across the United States, Europe, the Middle East, and Africa. The company's core product offerings, Eversense and Eversense XL, are advanced implantable CGM devices.
Analysis Summary
Senseonics Holdings, Inc. reported revenue of $35.3M in the most recent fiscal year, growing at a 5-year CAGR of 48.1%.
Trailing-twelve-month margins: gross margin 54.9%, operating margin -223.2%, net margin -225.3%.
At the current price of $9.06, SENS has negative trailing earnings (P/E not meaningful) and an ROE of -113.21%. Market capitalisation stands at $379M.
Balance sheet quality for SENS: current ratio of 4.8. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 5.75 |
| EV / EBITDA | -3.69 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $-21.68 |
| vs Current Price | -339.3% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| SENS | Senseonics Holdings, Inc. | $379M | 5.75 | -113.2% | |
| ABT | Abbott Laboratories | $177.1B | 32.49 | 3.45 | 10.5% |
| 0Y6X.L | Medtronic Plc | $125.7B | |||
| MDT | Medtronic plc | $118.5B | 22.97 | 2.39 | 10.6% |
| SYK | Stryker Corporation | $109.2B | 29.95 | 4.66 | 16.4% |
| 0R2S.L | Stryker Corporation | $107.9B | 29.27 | 4.55 | 16.4% |
| 0HOY.L | Boston Scientific Corporation | $66.5B | 48.91 | 5.86 | 11.9% |
| BSX | Boston Scientific Corporation | $65.3B | 17.73 | 2.61 | 14.9% |
Price
| Price | $9.06 |
| Market Cap | $379M |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | -113.21% |
| Return on Invested Capital | -66.72% |
| Return on Assets | -54.73% |
| Gross Margin | 54.87% |
| Operating Margin | -223.22% |
| Net Margin | -225.34% |
Related companies: ACRS · CAPR · CERS · CVRX · MASS · NNOX · NPCE
Explore sector: Healthcare · Medical - Devices
More sections of SENS: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks